ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

133 hedge funds and large institutions have $1.14B invested in Alpine Immune Sciences, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 62 increasing their positions, 10 reducing their positions, and 9 closing their positions.

Holders
133
Holders Change
+45
Holders Change %
+51.14%
% of All Funds
1.95%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.12%
New
55
Increased
62
Reduced
10
Closed
9
Calls
$140K
Puts
$25K
Net Calls
+$115K
Net Calls Change
+$94K

Top Buyers

1
DC
1
Decheng Capital
California
$135M
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$72.7M
3
Morgan Stanley
3
Morgan Stanley
New York
$27.4M
4
Franklin Resources
4
Franklin Resources
California
$23.3M
5
Citadel Advisors
5
Citadel Advisors
Florida
$16.7M

Top Sellers

1
O
1
OrbiMed
New York
$48.3M
2
AG
2
Artal Group
Luxembourg
$967K
3
GTC
3
Ghost Tree Capital
New York
$0
4
APM
4
Avidity Partners Management
Texas
$0
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$4.55M
Name Market Value Shares Shares
Change 		Shares
Change %
DC
1
Decheng Capital
California
$135M 7,083,288 +7,083,288 New
RCM
2
RA Capital Management
Massachusetts
$93.6M 4,909,763 +218,585 +5%
LCM
3
Lynx1 Capital Management
Puerto Rico
$72.7M 3,813,926 +1,409,312 +59%
GPP
4
Great Point Partners
Connecticut
$70.6M 3,703,433 +624,800 +20%
PBA
5
Paradigm Biocapital Advisors
New York
$60.5M 3,176,743 +755,000 +31%
FLSM
6
Frazier Life Sciences Management
California
$59.7M 3,131,008 +145,251 +5%
BlackRock
7
BlackRock
New York
$58.3M 3,058,498 +706,581 +30%
CAM
8
Cormorant Asset Management
Massachusetts
$48.6M 2,550,000 +650,000 +34%
O
9
OrbiMed
New York
$48.3M 2,535,245 -1,546,347 -38%
Vanguard Group
10
Vanguard Group
Pennsylvania
$42.6M 2,234,767 +759,888 +52%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$32.2M 1,687,278 +290,834 +21%
CC
12
Commodore Capital
New York
$30.7M 1,610,000 +285,000 +22%
Morgan Stanley
13
Morgan Stanley
New York
$27.4M 1,437,482 +1,384,009 +2,588%
State Street
14
State Street
Massachusetts
$26.5M 1,390,029 +784,484 +130%
OCA
15
Octagon Capital Advisors
New York
$23.7M 1,241,300 +491,300 +66%
Franklin Resources
16
Franklin Resources
California
$23.3M 1,220,333 +1,220,333 New
WP
17
Woodline Partners
California
$19.1M 1,000,106 -38,671 -4%
Citadel Advisors
18
Citadel Advisors
Florida
$16.7M 875,257 +847,083 +3,007%
VC
19
Vivo Capital
California
$15.6M 819,275 -95,638 -10%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$14.6M 764,347 +135,422 +22%
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$13.6M 714,590 +714,590 New
Janus Henderson Group
22
Janus Henderson Group
United Kingdom
$11.1M 583,239 +583,239 New
IC
23
Ikarian Capital
Texas
$9.29M 487,248 +487,248 New
CS
24
Candriam SCA
Luxembourg
$8.96M 470,000 +470,000 New
Two Sigma Investments
25
Two Sigma Investments
New York
$7.21M 378,413 +187,824 +99%
1
2 3 4 5